Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Leopoldo Capecchi

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Annals of the Rheumatic Diseases|August 2, 2020
Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and SharmaPier Leopoldo Capecchi, Pietro Enea Lazzerini
European Heart Journal|March 20, 2026
Anti-Ro/SSA-antibody testing for isolated atrioventricular block in adults: a diagnostic and therapeutic work-upPietro Enea Lazzerini, Pier Leopoldo Capecchi, Mohamed Boutjdir
Journal of Hepatology|May 8, 2021
Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Stefano Brillanti
Circulation|April 15, 2020
COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!Pietro Enea Lazzerini, Mohamed Boutjdir, Pier Leopoldo Capecchi
European Heart Journal|October 25, 2022
Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the 'dark side of the immune'Pietro Enea Lazzerini, Mohamed Boutjdir, Pier Leopoldo Capecchi
Circulation|November 23, 2020
Letter by Lazzerini et al Regarding Article, "Autoantibody Signature in Cardiac Arrest"Pietro Enea Lazzerini, Mohamed Boutjdir, Pier Leopoldo Capecchi
Lupus Science & Medicine|January 12, 2017
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfallsPietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini
Journal of Cardiovascular Electrophysiology|June 23, 2011
The "invulnerability" of the adult conduction system to anti-Ro/SSA antibodies? A matter of calcium channel expression on the cardiomyocytePietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini
Cardiovascular Drugs and Therapy|July 9, 2013
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy: editorial to "Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice" by K. Tajiri et alPietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini
Heart Rhythm|December 3, 2014
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implicationsPietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Annals of the Rheumatic Diseases|August 2, 2020
Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and SharmaPier Leopoldo Capecchi, Pietro Enea Lazzerini
European Heart Journal|March 20, 2026
Anti-Ro/SSA-antibody testing for isolated atrioventricular block in adults: a diagnostic and therapeutic work-upPietro Enea Lazzerini, Pier Leopoldo Capecchi, Mohamed Boutjdir
Journal of Hepatology|May 8, 2021
Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Stefano Brillanti
Circulation|April 15, 2020
COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!Pietro Enea Lazzerini, Mohamed Boutjdir, Pier Leopoldo Capecchi
European Heart Journal|October 25, 2022
Anti-Ro/SSA-antibodies and heart rhythm disturbances in the general population: the 'dark side of the immune'Pietro Enea Lazzerini, Mohamed Boutjdir, Pier Leopoldo Capecchi
Circulation|November 23, 2020
Letter by Lazzerini et al Regarding Article, "Autoantibody Signature in Cardiac Arrest"Pietro Enea Lazzerini, Mohamed Boutjdir, Pier Leopoldo Capecchi
Lupus Science & Medicine|January 12, 2017
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfallsPietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini
Journal of Cardiovascular Electrophysiology|June 23, 2011
The "invulnerability" of the adult conduction system to anti-Ro/SSA antibodies? A matter of calcium channel expression on the cardiomyocytePietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini
Cardiovascular Drugs and Therapy|July 9, 2013
Statins as a new therapeutic perspective in myocarditis and postmyocarditis dilated cardiomyopathy: editorial to "Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice" by K. Tajiri et alPietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini
Heart Rhythm|December 3, 2014
Isolated atrioventricular block of unknown origin in adults and anti-Ro/SSA antibodies: clinical evidence, putative mechanisms, and therapeutic implicationsPietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini
Pageof 11